Welcome to the largest gathering for mRNA professionals
With over 800 mRNA drugs now in development and the industry accelerating towards clinical success, the mRNA-Based Therapeutics Summit returns for its 3rd year as the industry’s largest networking opportunity to date, showcasing exclusive new data from the movers and shakers in the field.
Ensure your whole team stays ahead of the curve by joining 300+ key mRNA opinion leaders from Moderna, BioNTech, Sanofi including regulatory insights from the FDA and EMA at the world’s only end-to-end meeting focused on the next generation of mRNA-based therapeutics and vaccines.
Expect 100+ world-class speakers from large pharma, innovative biotechs, and academia, with 3 days of jam-packed content with 5 dedicated tracks (discovery, translation, clinical development, chemistry, manufacturing and controls (CMC) and logistics) deep-dive focus and workshop days, C-Level Fireside Discussions and more, enabling you to overcome industry hurdles including optimized dosing, targeted delivery, safety and scalability to achieve regulatory success in infectious and rare diseases, cancer and beyond!
Among Our World-Class Speaker Faculty
Peter Marks
Director - Center For Biologics Evaluation & Research
US Food & Drug Administration (FDA)
Companies Attending
The Biggest Meeting in the mRNA Calendar
300+
Attendees
100+
World-Class Speakers
10+
Hours of Dedicated In-Person Networking
5
Tracks of Content
2
Pre-Conference Days
1
Pre-Conference Workshop Day
5
Interactive Panel Discussions
Lead Partner
Hosting Partners
Expertise Partners
